Moataz B. Zewail

696 citations

19 papers · 482 indexed · h-index 13

Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems 5
- Drug Solubulity and Delivery Systems 4
- Advancements in Transdermal Drug Delivery 3
Applied Microbiology and Biotechnology top 10%
Cancer Research
Molecular Medicine
Biomaterials
- Nanoparticle-Based Drug Delivery 2
Rheumatology
- Systemic Lupus Erythematosus Research 3
- Rheumatoid Arthritis Research and Therapies 3
Molecular Biology
- RNA Interference and Gene Delivery 2
Endocrinology, Diabetes and Metabolism
- Natural Antidiabetic Agents Studies 2

Co-authors: Walaa A. El‐Dakroury Gihan F. Asaad Ahmed S. Doghish Sanaa A. El‐Gizawy Hussein M. El‐Husseiny Eman A. Mady Marwa E. Shabana Yusuf A. Haggag
Cited by: Pharmaceutical Science Applied Microbiology and Biotechnology Cancer Research
Partner nations: Egypt Australia Saudi Arabia

In The Last Decade

Moataz B. Zewail

18 papers receiving 476 citations

Peers

Countries citing papers authored by Moataz B. Zewail

Since Specialization

Citations

This map shows the geographic impact of Moataz B. Zewail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moataz B. Zewail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moataz B. Zewail more than expected).

Fields of papers citing papers by Moataz B. Zewail

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moataz B. Zewail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moataz B. Zewail. The network helps show where Moataz B. Zewail may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Moataz B. Zewail, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Moataz B. Zewail Line = papers co-authored together Moataz B. Zewail links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery Moataz B. Zewail,Guangze Yang,Yilong Fan,Yue Hui,Chun‐Xia Zhao,Yun Liu	2025	7
2	A novel furo[2,3- d ]pyrimidine-based chalcone derivative (MMK-1931) loaded chitosomes as a potential cancer therapy in an Ehrlich ascites tumour model Walaa A. El‐Dakroury,Moataz B. Zewail,Mai A. Mansour,Osama A. Mohammed,Ahmed S. Doghish,Ahmed Senbel,Al-Aliaa M. Sallam,Mostafa I. Gebril,Khaled A. M. Abouzid,Mina Noshy,Yousra Nomier,Mamdouh A. Oraby	2025	1
3	Investigating the potential of quercetin-loaded chitosan-coated lipid carriers as an oral nanoplatform for depression management Moataz B. Zewail,Yousra Nomier,Ahmed E. Elesawy,Walaa A. El‐Dakroury	2025	2
4	Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis Walaa A. El‐Dakroury,Moataz B. Zewail,Gihan F. Asaad,Heba M. I. Abdallah,Marwa E. Shabana,Abdelrahman R. Said,Ahmed S. Doghish,Hadeer A. Azab,Dalia H H Amer,Ahmed Hassan,Alaa S. Sayed,Ghada M. Samra,Al-Aliaa M. Sallam	2024	24
5	Lipid-based nanocarriers: an attractive approach for rheumatoid arthritis management Moataz B. Zewail,Ahmed S. Doghish,Hussein M. El‐Husseiny,Eman A. Mady,Osama A. Mohammed,Abdullah M. M. Elbadry,Amir S. Elbokhomy,Abdelmenem Bhnsawy,Walaa A. El‐Dakroury	2024	9
6	PEGylated lipid polymeric nanoparticles for management of rheumatoid arthritis Moataz B. Zewail,Gihan F. Asaad,Marwa E. Shabana,Amir S. Elbokhomy,Abdullah M. M. Elbadry,Peter Y. Riad,Ghidaa A. Salama,Walaa A. El‐Dakroury	2024	7
7	Smart/stimuli-responsive chitosan/gelatin and other polymeric macromolecules natural hydrogels vs. synthetic hydrogels systems for brain tissue engineering: A state-of-the-art review Hussein M. El‐Husseiny,Eman A. Mady,Ahmed S. Doghish,Moataz B. Zewail,Amr M. Abdelfatah,Mina Noshy,Osama A. Mohammed,Walaa A. El‐Dakroury	2024	21
8	Overview of Cancer and Treatment Challenges: Harnessing the Anti-cancer Potential of Jasminum Sambac and its Nanoparticle Formulations Yousra Nomier,Anugeetha Thacheril Mohanan,Walaa A El Dakroury,Dallin A Hassan,Sermugapandian Nithya,Aamena Jabeen,E. M. Mohammed,Moataz B. Zewail,Gihan F. Asaad,Zeinah Y Abbady	2024	0
9	miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma Osama A. Mohammed,Amr Mohamed Yehia,Elsayed G.E. Elsakka,Ahmed I. Abulsoud,Nourhan M. Abdelmaksoud,Ahmed Elshafei,Samy Y. Elkhawaga,Ahmed Ismail,Mahmoud Mohamed Mokhtar,Hesham A. El‐Mahdy,Maghawry Hegazy,Mohammed S. Elballal,Osama A. Mohammed,Hussein M. El‐Husseiny,Heba M. Midan,Walaa A. El‐Dakroury,Moataz B. Zewail,Sherif S. Abdel Mageed,Ahmed S. Doghish	2023	25
10	Development of famotidine-loaded lecithin-chitosan nanoparticles for prolonged and efficient anti-gastric ulcer activity Moataz B. Zewail,Sanaa A. El‐Gizawy,Gihan F. Asaad,Walaa A. El‐Dakroury	2023	14
11	miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma Tohada M. AL‐Noshokaty,Mohammed S. Elballal,Gouda K. Helal,Ahmed I. Abulsoud,Shereen Saeid Elshaer,Ahmed A. El-Husseiny,Doaa Fathi,Nourhan M. Abdelmaksoud,Sherif S. Abdel Mageed,Heba M. Midan,Mohamed Bakr Zaki,Mai A. Abd‐Elmawla,Nehal I. Rizk,Mahmoud A. Elrebehy,Moataz B. Zewail,Osama A. Mohammed,Ahmed S. Doghish	2023	20
12	Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis Moataz B. Zewail,Sanaa A. El‐Gizawy,Gihan F. Asaad,Marwa E. Shabana,Walaa A. El‐Dakroury	2023	30
13	miRNAs orchestration of gallbladder cancer – Particular emphasis on diagnosis, progression and drug resistance Reem K. Shahin,Osama A. Mohammed,Ahmed I. Abulsoud,Nourhan M. Abdelmaksoud,Sherif S. Abdel Mageed,Walaa A. El‐Dakroury,Moataz B. Zewail,Mahmoud Elazazy,Mohamed H. Sobhy,Yousra Nomier,Ola Elazazy,Mohammed S. Elballal,Osama A. Mohammed,Heba M. Midan,Mahmoud A. Elrebehy,Bassant O. Ziada,Ahmed S. Doghish	2023	30
14	Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation Moataz B. Zewail,Gihan F. Asaad,Salma M. Swellam,Sama M. Abd-allah,Sahar K.Hosny,Salma K. Sallah,Jehan E.Eissa,Salma S.Mohamed,Walaa A. El‐Dakroury	2022	58
15	Smart/stimuli-responsive hydrogels: State-of-the-art platforms for bone tissue engineering Hussein M. El‐Husseiny,Eman A. Mady,Walaa A. El‐Dakroury,Moataz B. Zewail,Mina Noshy,Amr M. Abdelfatah,Ahmed S. Doghish	2022	81
16	Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant/type 2 diabetic rat model Walaa A. El‐Dakroury,Moataz B. Zewail,Mohamed M. Amin	2022	45
17	Preparation and In vitro characterization of a novel self-nano emulsifying drug delivery system for a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide Moataz B. Zewail,Sanaa A. El‐Gizawy,Mohammed Osman,Yusuf A. Haggag	2021	41
18	Famotidine-loaded solid self-nanoemulsifying drug delivery system demonstrates exceptional efficiency in amelioration of peptic ulcer Walaa A. El‐Dakroury,Moataz B. Zewail,Mahmoud Elsabahy,Marwa E. Shabana,Gihan F. Asaad	2021	31
19	Antibiotic misuse and compliance with infection control measures during COVID‐19 pandemic in community pharmacies in Egypt Asmaa A. Elsayed,Samar F. Darwish,Moataz B. Zewail,Marwa Mohammed,Haitham Saeed,Hoda Rabea	2021	36

About Moataz B. Zewail

Moataz B. Zewail is a scholar working on Drug Discovery, Pharmaceutical Science and Applied Microbiology and Biotechnology, having authored 19 papers that have together received 482 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (4 papers), Advancements in Transdermal Drug Delivery (3 papers), Systemic Lupus Erythematosus Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), RNA Interference and Gene Delivery (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Natural Antidiabetic Agents Studies (2 papers). The work is most often cited by research in Pharmaceutical Science (111 citations), Applied Microbiology and Biotechnology (23 citations) and Cancer Research (106 citations). Moataz B. Zewail has collaborated with scholars based in Egypt, Australia and Saudi Arabia. Frequent co-authors include Walaa A. El‐Dakroury, Gihan F. Asaad, Ahmed S. Doghish, Sanaa A. El‐Gizawy, Hussein M. El‐Husseiny, Eman A. Mady, Marwa E. Shabana, Yusuf A. Haggag, Mohammed Osman and Osama A. Mohammed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact